These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

972 related articles for article (PubMed ID: 21538969)

  • 21. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond.
    ; Borowitz D; Parad RB; Sharp JK; Sabadosa KA; Robinson KA; Rock MJ; Farrell PM; Sontag MK; Rosenfeld M; Davis SD; Marshall BC; Accurso FJ
    J Pediatr; 2009 Dec; 155(6 Suppl):S106-16. PubMed ID: 19914443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective analysis of stored dried blood spots from children with cystic fibrosis and matched controls to assess the performance of a proposed newborn screening protocol in Switzerland.
    Barben J; Gallati S; Fingerhut R; Schoeni MH; Baumgartner MR; Torresani T;
    J Cyst Fibros; 2012 Jul; 11(4):332-6. PubMed ID: 22300503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening.
    Kay DM; Langfelder-Schwind E; DeCelie-Germana J; Sharp JK; Maloney B; Tavakoli NP; Saavedra-Matiz CA; Krein LM; Caggana M; Kier C;
    Pediatr Pulmonol; 2015 Aug; 50(8):771-80. PubMed ID: 26098992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
    Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K
    Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.
    Farrell PM; Koscik RE
    Pediatrics; 1996 Apr; 97(4):524-8. PubMed ID: 8632940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres.
    Terlizzi V; Claut L; Tosco A; Colombo C; Raia V; Fabrizzi B; Lucarelli M; Angeloni A; Cimino G; Castaldo A; Marsiglio L; Timpano S; Cirilli N; Moroni L; Festini F; Piccinini P; Zavataro L; Bonomi P; Taccetti G; Southern KW; Padoan R
    J Cyst Fibros; 2021 Sep; 20(5):828-834. PubMed ID: 33883100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes of children with intermediate sweat chloride values in infancy.
    Groves T; Robinson P; Wiley V; Fitzgerald DA
    J Pediatr; 2015 Jun; 166(6):1469-74.e1-3. PubMed ID: 25812778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystic fibrosis infant care challenges in diagnosis and management in the era of newborn screening.
    Padman R; Flathers K; Passi V
    Del Med J; 2012 May; 84(5):149-55. PubMed ID: 22866385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up.
    Narzi L; Ferraguti G; Stamato A; Narzi F; Valentini SB; Lelli A; Delaroche I; Lucarelli M; Strom R; Quattrucci S
    Clin Genet; 2007 Jul; 72(1):39-46. PubMed ID: 17594398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
    Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
    J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome.
    Gunnett MA; Baker E; Mims C; Self ST; Gutierrez HH; Guimbellot JS
    Front Pediatr; 2023; 11():1127659. PubMed ID: 36969284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?
    Scotet V; Audrézet MP; Roussey M; Rault G; Dirou-Prigent A; Journel H; Moisan-Petit V; Storni V; Férec C
    Pediatrics; 2006 Nov; 118(5):e1523-9. PubMed ID: 17015492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
    Corbetta C; Seia M; Bassotti A; Ambrosioni A; Giunta A; Padoan R
    J Med Screen; 2002; 9(2):60-3. PubMed ID: 12133923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic problems in cystic fibrosis - specific characteristics of a group of infants and young children diagnosed positive through neonatal screening, in whom cystic fibrosis had not been diagnosed.
    Woś H; Sankiewicz-Szkółka M; Więcek S; Kordys-Darmolińska B; Grzybowska-Chlebowczyk U; Kniażewska M
    Dev Period Med; 2015; 19(1):25-31. PubMed ID: 26003067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial concordance of phenotype and microbial variation among siblings with CF.
    Picard E; Aviram M; Yahav Y; Rivlin J; Blau H; Bentur L; Avital A; Villa Y; Schwartz S; Kerem B; Kerem E
    Pediatr Pulmonol; 2004 Oct; 38(4):292-7. PubMed ID: 15334505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS/CFSPID subjects: A systematic review.
    Terlizzi V; Manti S; D'Amico F; Parisi GF; Chiappini E; Padoan R
    Paediatr Respir Rev; 2024 Sep; 51():46-55. PubMed ID: 38309973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.